Peptide sequences are provided which are capable of mimicking proteins
encoded by HCV for use as reagents for screening of blood and blood
products for prior exposure to HCV. The peptides are at least 5 amino
acids long and can be used in various specific assays for the detection of
antibodies to HCV, for the detection of HCV antigens, or as immunogens.
